Open AccessA Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone For Macular Edema Secondary to Branch Retinal Vein Occlusion
Author(s) -
Alper Halil Bayat
Publication year - 2019
Publication title -
beyoğlu eye journal (online)/beyoğlu eye journal
Language(s) - English
Resource type - Journals
eISSN - 2587-0394
pISSN - 2459-1777
DOI - 10.14744/bej.2019.18291
Subject(s) - medicine , ranibizumab , pro re nata , aflibercept , dexamethasone , macular edema , branch retinal vein occlusion , visual acuity , ophthalmology , regimen , intraocular pressure , retinal vein , occlusion , bevacizumab , surgery , chemotherapy
This study aims to compare the efficacy of intravitreal injection of aflibercept (IVA), ranibizumab (IVR) and dexamethasone implant (DEX IMP) for the treatment of macular edema (ME) secondary to branch retinal vein occlusion (BRVO).